跳至主要内容
临床试验/ISRCTN05107772
ISRCTN05107772已完成2 期

A Phase II prospective cohort study to assess the safety of a new MRI approach to pre-operatively stage rectal cancer and guide treatment

Mount Sinai Hospital (Canada)0 个研究点目标入组 82 人开始时间: 2014年7月23日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
82

研究概览

简要总结

2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/30973610 [added 12/04/2019]

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Diagnosis of rectal cancer (0-15 cm) from the anal verge on endoscopy and/or proximal extent of tumour at or below the sacral promontory on CT or MRI
  • 2. 18 years or older
  • 3. Able to provide written consent

排除标准

  • 1. Planned abdomino-perineal resection (APR) based on pre-treatment assessment
  • 2. Planned local excision based on pre-treatment assessment
  • 3. Suspicious extramesorectal lymph nodes on MRI
  • 4. Unable to undergo MRI due to claustrophobia, metal fragments, implanted metal devices or contrast allergy
  • 5. Metastatic disease (including extramesorectal lymph nodes, carcinomatosis, liver, lung)
  • 6. Pregnancy
  • 7. Inflammatory bowel disease
  • 8. Previous pelvic radiation
  • 9. More than one primary tumour

研究者

相似试验